Knockdown of long non-coding RNA SBF2-AS1 inhibits calcium oxalate-induced HK-2 cell injury by regulating the miR-302e/NLRP3 pathway
Urolithiasis · 2024
DOI: 10.1007/s00240-024-01606-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Urolithiasis, 2024. Verfasst von Hanliang Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Urology, Longgang District Central Hospital of Shenzhen, 6082 Longgang Avenue, Longgang District, Shenzhen City, 518116, Guangdong Province, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, MicroRNAs, RNA, Long Noncoding, Calcium Oxalate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Special Fund for Economic and Technological Development of Longgang District, Shenzhen, Shenzhen Longgang District Science and Technology Innovation Special Fund.
Abstract (Originalsprache)
Long non-coding ribose nucleic acids (lncRNAs) have been implicated in the development of nephrolithiasis. The study aims to investigate the interplay of lncRNA SBF2-AS1 (SETbinding factor 2 antisense RNA 1) and NLR family pyrin domain containing 3 (NLRP3) in regulating the calcium oxalate monohydrate (COM)-induced human kidney HK-2 cell injury. HK-2 cells were treated with COM (100 µg/mL) to create a cellular model of kidney injury. Gene and protein expression was assessed by quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) and Western blot. Proliferation and apoptosis rates, as well as levels of malondialdehyde (MDA), lactate dehydrogenase (LDH), superoxide dismutase (SOD), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were measured. Additionally, potential miRNAs interacting with SBF2-AS1 and NLRP3 were predicted utilizing the starBase and TargetScan databases. The interference of SBF2-AS1 resulted in increased cell proliferation and SOD levels in HK-2 cells after COM induction. SBF2-AS1 silencing also reduced COM-induced cell death and inflammatory cytokine production by down-regulating NLRP3 protein expression. Conversely, forced upregulation of NLRP3 abrogated the effect of SBF2-AS1 interference. Notably, SBF2-AS1 interference on COM-induced oxidative stress and COM-induced cellular damage was rescued by antioxidant, indicating the involvement of oxidative burden in COM-induced damage. miR-302e acted as a mediator miRNA linking the functional association of SBF2-AS1 and NLRP3. Silencing SBF2-AS1 promoted miR-302e level and miR-302e reduced NLRP3 expression in HK-2 cells to protect against COM-induced damage. In summary, these findings suggest that downregulation of lncRNA SBF2-AS1 can potentially protect HK-2 cells from COM-induced injury by modulating the miR-302e/NLRP3 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology, Longgang District Central Hospital of Shenzhen, 6082 Longgang Avenue, Longgang District, Shenzhen City, 518116, Guangdong Province, China.
- Urology, Longgang District Central Hospital of Shenzhen, 6082 Longgang Avenue, Longgang District, Shenzhen City, 518116, Guangdong Province, China. Dwdong951@163.com.
Förderung
- Special Fund for Economic and Technological Development of Longgang District, Shenzhen
- Shenzhen Longgang District Science and Technology Innovation Special Fund
Zitieren
APA
Zhu, H., Chen, Y., Zhong, Y., Xie, X., Zeng, X., & Deng, W. (2024). Knockdown of long non-coding RNA SBF2-AS1 inhibits calcium oxalate-induced HK-2 cell injury by regulating the miR-302e/NLRP3 pathway. Urolithiasis. https://doi.org/10.1007/s00240-024-01606-y
Vancouver
Zhu H, Chen Y, Zhong Y, Xie X, Zeng X, Deng W. Knockdown of long non-coding RNA SBF2-AS1 inhibits calcium oxalate-induced HK-2 cell injury by regulating the miR-302e/NLRP3 pathway. Urolithiasis. 2024. doi:10.1007/s00240-024-01606-y
BibTeX
@article{Zhu2024,
author = {Zhu, Hanliang and Chen, Yiwen and Zhong, Yuantang and Xie, Xiangwei and Zeng, Xiangjian and Deng, Wangdong},
title = {Knockdown of long non-coding RNA SBF2-AS1 inhibits calcium oxalate-induced HK-2 cell injury by regulating the miR-302e/NLRP3 pathway},
journal = {Urolithiasis},
year = {2024},
doi = {10.1007/s00240-024-01606-y}
}
EUVIMED